Related Experiment Video
Updated: Aug 13, 2026
Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
Malignant hepatic tumours in children: incidence, clinical features and aetiology
J R Mann1, N Kasthuri, F Raafat
1Department of Oncology, Children's Hospital, Birmingham.
Insights
Congenital defects were present in 21% of childhood malignant liver tumors. Hepatoblastoma is linked to maldevelopment, while hepatocellular carcinoma may arise from metabolic disorders leading to cirrhosis.
Area of Science:
- Pediatric Oncology
- Hepatobiliary Pathology
- Cancer Epidemiology
Background:
- Congenital defects and other disorders have been associated with malignant liver tumors in children.
- A population-based survey was conducted to assess the significance of these associations.
Purpose of the Study:
- To investigate the incidence and characteristics of primary malignant liver tumors in children under 15 years.
- To determine the association between congenital defects and specific types of childhood liver malignancies.
Main Methods:
- Data from 50 children diagnosed with malignant liver tumors between 1957-1986 were analyzed.
- Histological review of biopsies and necropsy materials by a panel of three pediatric pathologists.
- Exclusion of cases with non-malignant conditions, extrahepatic malignancies, or unavailable pathological material.
Main Results:
- 42 cases were confirmed, with diagnoses including hepatoblastoma (27), hepatocellular carcinoma (3), rhabdomyosarcoma (6), rhabdoid tumor (3), and yolk sac tumor (3).
- The incidence of primary malignant liver tumors was 1.20 per 10^6 person-years; hepatoblastoma incidence was 0.77 per 10^6 person-years.
- Congenital defects or related features were present in 9 (21%) patients.
Conclusions:
- Hepatoblastoma appears to be a malignant tumor associated with maldevelopment, potentially linked to 11p or 5q mutations.
- Hepatocellular carcinoma is more commonly a complication of metabolic disorders leading to cirrhosis.
Abstract:
Congenital defects and other disorders have been reported in association with malignant liver tumours. In order to assess their significance, a population-based survey was undertaken on children aged less than 15 years diagnosed with malignant liver tumours during the 30 years 1957-1986. The cases were identified from information collected by the West Midlands Regional Children's Tumour Registry. Pertinent data were extracted from their clinical records, and the original biopsy and any necropsy material were reviewed by a panel of three paediatric pathologists. Of the 50 eligible cases registered, eight were excluded because histology review showed that they had non-malignant conditions (3) or malignancies of extrahepatic origin (4) or because no pathological material was available (1). The diagnoses in the remaining 42 cases were hepatoblastoma (27), hepatocellular carcinoma (3), rhabdomyosarcoma (6), rhabdoid tumour (3) and yolk sac tumour (3). The incidence of primary malignant liver tumours was 1.20 per 10(6) person years and that of the hepatoblastoma sub-group was 0.77 (average childhood population of the West Midlands for the time period being 1,166,500). The presenting clinical, radiological and biochemical features were similar to those reported in other series and the ethnic and social class distributions were unremarkable compared with the local population. Congenital defects or other possibly related features were present in nine (21%) patients. Our results, taken with other reports, suggest that hepatoblastoma is a malignant tumour related to maldevelopment, possibly associated with 11p or 5q mutations, whereas hepatocellular carcinoma is more usually a complication of metabolic and other disorders which lead to cirrhosis.
